MedReleaf Australia

What MedReleaf Australia does

MedReleaf Australia (legal entity Indica Industries Pty Ltd) is a Brisbane-based pharmaceutical company that distributes a portfolio of medicinal cannabis products to Australian pharmacies and healthcare professionals. Founded in 2016 and operating as a wholly-owned subsidiary of Canadian-listed Aurora Cannabis Inc. (NYSE: ACB), the company offers products under the MedReleaf, IndiMed, Aurora, and Whistler Cannabis Co. brands. Its stated technology footprint is the MedReleafED education portal, a free clinical-support and training resource for doctors, nurse practitioners, and pharmacists, which functions as the primary demand-generation and prescriber-engagement layer.

The business operates on a B2B distribution model rather than direct-to-patient. Revenue is generated by supplying TGA-compliant medicinal cannabis products through pharmacy wholesalers and an online distribution platform. Distribution is handled through three principal channels: Vitura Health's Canview platform (reaching approximately 4,700 Australian pharmacies via the Burleigh Heads Cannabis network), Symbion Pty Ltd as a CSO wholesaler for controlled-substance logistics, and the broader Burleigh Heads Cannabis pharmacy network. Pricing is not publicly disclosed and is gated behind MedReleafED registration.

Customer segments are prescribers (doctors, nurse practitioners) and pharmacists, with patients as the end consumer. The company monetizes primarily through product sale margins on medicinal cannabis, with a secondary go-to-market investment in prescriber education and clinical support services. The most material recent commercial lever is the March 2026 Vitura Health distribution agreement, projected by Vitura to contribute up to AUD $15 million in additional annual revenue subject to demand and regulatory conditions.

Name

MedReleaf Australia

Legal name

Indica Industries Pty Ltd t/as MedReleaf Australia

Website

https://medreleafaustralia.com.au

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

MedReleaf Australia distributes a portfolio of TGA-compliant medicinal cannabis products under multiple brands to Australian pharmacies and prescribers, operating as a wholly-owned subsidiary of Aurora Cannabis and supported by the MedReleafED prescriber education platform.

Ownership category

akta.pro rank

Product category

Medicinal Cannabis Pharmaceuticals

NAICS

Pharmacies and Drug Retailers (456110), Medicinal and Botanical Manufacturing (325411)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)

akta.pro secondary industries

Medical Cannabis Delivery & Online Ordering (CRANAGAG), Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail) (CRANAFAG)

Keywords

• Medicinal cannabis
• Pharmaceutical distribution
• Cannabis education
• Pharmacy wholesale
• TGA-approved cannabis

Headquarters

HQ city

Coorparoo

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Medicinal Cannabis Products: MedReleaf Australia generates revenue through the sale of medicinal cannabis products under brands including MedReleaf, IndiMed, Aurora, and Whistler Cannabis Co. Products are distributed to pharmacies through distribution partners.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

MedReleaf Australia distributes a portfolio of TGA-compliant medicinal cannabis products under the brands MedReleaf, IndiMed, Aurora, and Whistler Cannabis Co. to Australian pharmacies and healthcare professionals. The company supplements its product distribution with the MedReleafED education platform, which provides complimentary clinical training, webinars, and prescribing support to doctors, nurse practitioners, and pharmacists nationwide.

Product overview

MedReleaf Australia is a pharmaceutical company offering a portfolio of medicinal cannabis products under multiple brands (MedReleaf, IndiMed, Aurora, and Whistler Cannabis Co.), distributed through pharmacy networks across Australia. The company operates primarily as a business-to-business entity, supplying medicinal cannabis to healthcare professionals and pharmacies rather than directly to patients. Alongside its product portfolio, MedReleaf Australia provides MedReleafED, a complimentary education and clinical support platform for doctors, nurse practitioners, and pharmacists to support safe and informed prescribing of medicinal cannabis.

Differentiator

Problem solved

Functional benefit

Brands

• MedReleaf: Primary brand for medicinal cannabis products
• IndiMed
• Aurora
• Whistler Cannabis Co.
• MedReleafED
• Canview

Products and services

• MedReleaf medicinal cannabis products Primary brand of medicinal cannabis products distributed by MedReleaf Australia through pharmacy networks across Australia, targeting patients with valid prescriptions from authorised prescribers.
• IndiMed medicinal cannabis products Sub-brand of medicinal cannabis products offered within the MedReleaf Australia portfolio, targeting Australian patients through pharmacy dispensing channels.
• Aurora medicinal cannabis products Global medicinal cannabis brand distributed by MedReleaf Australia, originally developed by parent company Aurora Cannabis Inc. and made available to Australian patients through pharmacy networks.
• Whistler Cannabis Co. products Cannabis brand available through MedReleaf Australia's distribution network to Australian pharmacies and patients.
• MedReleafED clinical education platform Clinical education platform offering complimentary clinical support, training, webinars, and educational resources for doctors, nurse practitioners, and pharmacists on medicinal cannabis prescribing and dispensing in Australia.

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Four partnerships are on record, tiered core and minor.

• Vitura HealthcoreChannel Partner/ Reseller/ Distributor · 17 March 2026Commercial distribution agreement with Vitura Health (ASX: VIT) to make MedReleaf's full suite of medicinal cannabis products available on Vitura's Canview online platform, distributed through the Burleigh Heads Cannabis nationwide network. Vitura estimates the deal could contribute up to $15 million in additional annual revenue.
• Aurora CannabiscoreOEM/ Whitelabel/ Licensing PartnerMedReleaf is a wholly owned subsidiary of Canadian-based Aurora Cannabis. Products are offered under brands including MedReleaf, IndiMed, Aurora, and Whistler Cannabis Co.
• CleanHubminorStrategic or Co-development PartnerEnvironmental partnership where MedReleaf Australia has partnered with CleanHub to offset a portion of plastic use by funding the collection of plastic waste to prevent it from polluting oceans.
• Symbion Pty LtdcoreChannel Partner/ Reseller/ DistributorPharmacy wholesaler with which MedReleaf Australia has established a storage and distribution agreement for CSO (Controlled Substances Operator) operations.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Little Green Pharma: ASX-listed Australian medicinal cannabis cultivator and distributor. Operates in the same TGA-regulated market, supplying prescribers and pharmacies with cannabinoid medicines — directly comparable in product category, customer base, and regulatory environment.
• Cann Group: ASX-listed Australian medicinal cannabis producer and supplier. Competes in the same regulated channel — TGA-approved cultivation, B2B supply to pharmacies and prescribers — with overlapping customer segments.
• Althea Group: Australian medicinal cannabis company distributing via pharmacy networks and providing prescriber education. Closely comparable business model targeting doctors, nurse practitioners, and pharmacists in Australia.
• Bod Australia: ASX-listed medicinal cannabis and CBD wellness company. Targets overlapping prescriber and pharmacy channels with cannabis-based therapeutic products, competing in the same clinical segment.
• Incannex Healthcare: ASX-listed clinical-stage cannabinoid and psychedelic medicine developer. Operates in the Australian medicinal cannabis regulatory framework and targets similar prescriber and pharmacy customers.
• ECS Botanics: ASX-listed Australian medicinal cannabis cultivator and manufacturer. Distributes TGA-compliant products to the same pharmacy and prescriber network as MedReleaf.
• Zelira Therapeutics: Clinical-stage cannabinoid medicine company listed on the ASX. Competes in the same Australian medicinal cannabis regulatory and distribution environment targeting prescribers.

Broad incumbents

• Vitura Health: ASX-listed parent of the Canview platform and Burleigh Heads Cannabis network — MedReleaf's primary distribution partner. A broader cannabis healthcare company with overlapping exposure to the Australian pharmacy channel and a wider product portfolio including non-cannabis wellness lines.
• Aurora Cannabis: NYSE/TSX-listed global cannabis operator and MedReleaf Australia's parent. Directly comparable product portfolio (medical cannabis brands) and operates at much larger scale across multiple international markets.

Emerging players

• Montu: Australian medicinal cannabis platform connecting patients, prescribers, and pharmacies. Comparable in channel and customer focus, but operates a more vertically integrated patient-acquisition model rather than a wholesale distribution approach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/medreleaf-australia
• Xx.com/medreleafaust

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MedReleaf Australia